Publication details

On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes

Authors

NOSÁL Radomír DRÁBIKOVÁ Katarína JANČINOVÁ Viera PEREČKO Tomáš AMBROŽOVÁ Gabriela ČÍŽ Milan LOJEK Antonín PEKAROVÁ Michaela ŠMIDRKAL Jan HARMATHA Juraj

Year of publication 2014
Type Article in Periodical
Magazine / Source Oxidative Medicine and Cellular Longevity
Citation
Web https://www.hindawi.com/journals/omcl/2014/706269/abs/
Doi http://dx.doi.org/10.1155/2014/706269
Keywords Resveratrol, Oxidative Burst, Professional Phagocytes
Description Resveratrol—3,5,4'-trihydroxystilbene—possesses antioxidant activities in vitro. It dose-dependently inhibited the generation of peroxyl, hydroxyl, peroxides, and lipid peroxidation products in cell free systems. Oxidative burst of whole human blood stimulated with PMA, fMLP, OpZ, and A23187 was inhibited in a concentration-dependent way, indicating suppression of both receptor and nonreceptor activated chemiluminescence by resveratrol. Results from isolated human neutrophils revealed that resveratrol was active extracellularly as well as intracellularly in inhibiting the generation of reactive oxygen species. Liberation of ATP and analysis of apoptosis showed that in the concentration of 100?µM, resveratrol did not change the viability and integrity of isolated neutrophils. Western blot analysis documented that resveratrol in concentrations of 10 and 100?µM significantly decreased PMA-induced phosphorylation of PKC ?/ßII. Dose-dependent inhibition of nitrite production and iNOS protein expression in RAW 264.7 cells indicated possible interference of resveratrol with reactive nitrogen radical generation in professional phagocytes. The results suggest that resveratrol represents an effective naturally occurring substance with potent pharmacological effect on oxidative burst of human neutrophils and nitric oxide production by macrophages. It should be further investigated for its pharmacological activity against oxidative stress in ischaemia reperfusion, inflammation, and other pathological conditions, particularly neoplasia.

You are running an old browser version. We recommend updating your browser to its latest version.

More info